Johnson & Johnson to pay $1.75M in Risperdal trial
NorthJersey.com recently reported that a jury ordered well-known pharmaceutical manufacturer Johnson & Johnson to pay approximately $1.75 million to 21-year-old Nicholas Murray from Maryland after he developed female breasts after taking the company’s anti-psychotic drug, Risperdal.
The report said that the jury concluded that Johnson & Johnson failed to advise patients and doctors that Risperdal could trigger abnormal breast development in males. The verdict granted damages for disfigurement and mental anguish to Murray.
The recent ruling is just one out of approximately 5,400 Risperdal cases against Johnson & Johnson and its Janssen unit. According to the report, in the same state court where Murray’s case was decided, there are about 1,500 other Risperdal lawsuits that have been filed by men who developed breasts after using the anti-psychotic drug.
If you or a loved one has suffered adverse and unadvertised side effects after taking Risperdal, help is available. Contact the experienced Risperdal lawsuit attorneys of Williams Kherkher by calling us today at (800) 220-9341.